Literature DB >> 17081987

Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex.

Douglas I Lin1, Olena Barbash, K G Suresh Kumar, Jason D Weber, J Wade Harper, Andres J P Klein-Szanto, Anil Rustgi, Serge Y Fuchs, J Alan Diehl.   

Abstract

Growth factor-dependent accumulation of the cyclin D1 proto-oncogene is balanced by its rapid phosphorylation-dependent proteolysis. Degradation is triggered by threonine 286 phosphorylation, which promotes its ubiquitination by an unknown E3 ligase. We demonstrate that Thr286-phosphorylated cyclin D1 is recognized by a Skp1-Cul1-F box (SCF) ubiquitin ligase where FBX4 and alphaB crystallin govern substrate specificity. Overexpression of FBX4 and alphaB crystallin triggered cyclin D1 ubiquitination and increased cyclin D1 turnover. Impairment of SCF(FBX4-alphaB crystallin) function attenuated cyclin D1 ubiquitination, promoting cyclin D1 overexpression and accelerated cell-cycle progression. Purified SCF(FBX4-alphaB crystallin) catalyzed polyubiquitination of cyclin D1 in vitro. Consistent with a putative role for a cyclin D1 E3 ligase in tumorigenesis, FBX4 and alphaB crystallin expression was reduced in tumor-derived cell lines and a subset of primary human cancers that overexpress cyclin D1. We conclude that SCF(FBX4-alphaB crystallin) is an E3 ubiquitin ligase that promotes ubiquitin-dependent degradation of Thr286-phosphorylated cyclin D1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17081987      PMCID: PMC1702390          DOI: 10.1016/j.molcel.2006.09.007

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  47 in total

1.  Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.

Authors:  Tarig Bashir; N Valerio Dorrello; Virginia Amador; Daniele Guardavaccaro; Michele Pagano
Journal:  Nature       Date:  2004-03-11       Impact factor: 49.962

2.  F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex.

Authors:  D Skowyra; K L Craig; M Tyers; S J Elledge; J W Harper
Journal:  Cell       Date:  1997-10-17       Impact factor: 41.582

3.  Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.

Authors:  J A Diehl; F Zindy; C J Sherr
Journal:  Genes Dev       Date:  1997-04-15       Impact factor: 11.361

4.  Mimicking phosphorylation of the small heat-shock protein alphaB-crystallin recruits the F-box protein FBX4 to nuclear SC35 speckles.

Authors:  John den Engelsman; Erik J Bennink; Linda Doerwald; Carla Onnekink; Lisa Wunderink; Usha P Andley; Kanefusa Kato; Wilfried W de Jong; Wilbert C Boelens
Journal:  Eur J Biochem       Date:  2004-11

Review 5.  Cancer cell cycles.

Authors:  C J Sherr
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

6.  Antizyme targets cyclin D1 for degradation. A novel mechanism for cell growth repression.

Authors:  Ruchi M Newman; Arian Mobascher; Ursula Mangold; Chieko Koike; Sri Diah; Marion Schmidt; Daniel Finley; Bruce R Zetter
Journal:  J Biol Chem       Date:  2004-07-23       Impact factor: 5.157

7.  Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

Authors:  D E Quelle; R A Ashmun; S A Shurtleff; J Y Kato; D Bar-Sagi; M F Roussel; C J Sherr
Journal:  Genes Dev       Date:  1993-08       Impact factor: 11.361

8.  Cyclin-dependent regulation of G1 in mammalian fibroblasts.

Authors:  M Ohtsubo; J M Roberts
Journal:  Science       Date:  1993-03-26       Impact factor: 47.728

9.  Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle.

Authors:  H Matsushime; M F Roussel; R A Ashmun; C J Sherr
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

10.  Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system.

Authors:  D Resnitzky; M Gossen; H Bujard; S I Reed
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

View more
  170 in total

1.  FBXO4 inhibits lung cancer cell survival by targeting Mcl-1 for degradation.

Authors:  C Feng; F Yang; J Wang
Journal:  Cancer Gene Ther       Date:  2017-08-04       Impact factor: 5.987

2.  Cyclin D1b in human breast carcinoma and coexpression with cyclin D1a is associated with poor outcome.

Authors:  Vandana Gupta Abramson; Andrea B Troxel; Michael Feldman; Carolyn Mies; Yan Wang; Lauren Sherman; Sara McNally; Alan Diehl; Angela Demichele
Journal:  Anticancer Res       Date:  2010-04       Impact factor: 2.480

3.  The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve the E3 ligase TBLR1.

Authors:  Aurore Keutgens; Kateryna Shostak; Pierre Close; Xin Zhang; Benoît Hennuy; Marie Aussems; Jean-Paul Chapelle; Patrick Viatour; André Gothot; Marianne Fillet; Alain Chariot
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

Review 4.  Novel roles for α-crystallins in retinal function and disease.

Authors:  Ram Kannan; Parameswaran G Sreekumar; David R Hinton
Journal:  Prog Retin Eye Res       Date:  2012-06-18       Impact factor: 21.198

5.  NIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressor.

Authors:  Tsutomu Mori; Daisuke D Ikeda; Toshihiko Fukushima; Seiichi Takenoshita; Hideo Kochi
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

Review 6.  Ubiquitination-mediated degradation of cell cycle-related proteins by F-box proteins.

Authors:  Nana Zheng; Zhiwei Wang; Wenyi Wei
Journal:  Int J Biochem Cell Biol       Date:  2016-02-06       Impact factor: 5.085

Review 7.  The lens epithelium: focus on the expression and function of the alpha-crystallin chaperones.

Authors:  Usha P Andley
Journal:  Int J Biochem Cell Biol       Date:  2007-11-13       Impact factor: 5.085

8.  αB-Crystallin regulates expansion of CD11b⁺Gr-1⁺ immature myeloid cells during tumor progression.

Authors:  Lothar C Dieterich; Petter Schiller; Hua Huang; Eric F Wawrousek; Angelica Loskog; Alkwin Wanders; Lieve Moons; Anna Dimberg
Journal:  FASEB J       Date:  2012-10-02       Impact factor: 5.191

Review 9.  Cyclin D1, cancer progression, and opportunities in cancer treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  J Mol Med (Berl)       Date:  2016-10-02       Impact factor: 4.599

Review 10.  Breaking down protein degradation mechanisms in cardiac muscle.

Authors:  Robert C Lyon; Stephan Lange; Farah Sheikh
Journal:  Trends Mol Med       Date:  2013-02-27       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.